anmelden
Novavax Aktie
6,88
EUR
+0,07
EUR
+0,95
%
7,92
USD
-0,03
USD
-0,31
%
nachbörslich
Novavax jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Marktkap. 1,13 Mrd. EUR
KGV 2,64Div. Rendite 0,00%WKN A2PKMZ
ISIN US6700024010
Symbol NVAX
AI Analyse
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| AstraZeneca PLC | 8 | 0 | 1 | 164,21 GBP | - |
| Bayer | 7 | 2 | 0 | 55,31 EUR | +12,60% |
| BioNTech (ADRs) | 5 | 1 | 0 | 128,83 USD | +38,83% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 0 | 0 | - | - |
| Fresenius Medical Care (FMC) St. | 2 | 4 | 3 | 40,81 EUR | -3,61% |
| Fresenius SE & Co. KGaA (St.) | 6 | 1 | 0 | 54,28 EUR | +14,64% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Inovio Pharmaceuticals Inc | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Moderna Inc | 0 | 1 | 0 | 45,00 USD | -25,71% |
| Novartis AG | 2 | 6 | 1 | 123,10 CHF | -2,19% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 2 | 5 | 1 | 27,14 USD | +1,95% |
| Roche Holding AG Inhaber-Partizipationsschein | 3 | 4 | 1 | - | - |
| Sanofi S.A. | 5 | 4 | 0 | 93,53 EUR | +23,73% |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |
